FDA Inspection 866251 — Carter BloodCare At Grand Prairie
The FDA completed an inspection of Carter BloodCare At Grand Prairie on Feb 13, 2014 in Grand Prairie, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Feb 13, 2014
- Fiscal Year
- 2014
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Grand Prairie, TX (United States)